Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle F Maritz

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Pharmaceutics|May 25, 2022
Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpointParisa Badiee, Michelle F Maritz, Benjamin Thierry
International Journal of Pharmaceutics|February 17, 2022
High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer modelsPouya Dehghankelishadi, Michelle F Maritz, Parisa Badiee, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Assessment and quantification of telomerase enzyme activityMichelle F Maritz, Laura A Richards, Karen L Mackenzie
ACS Applied Materials & Interfaces|March 31, 2022
Intratumoral Anti-PD-1 Nanoformulation Improves Its BiodistributionParisa Badiee, Michelle F Maritz, Nicole Dmochowska, et al.
Journal of Nanobiotechnology|March 22, 2023
Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effectsPouya Dehghankelishadi, Parisa Badiee, Michelle F Maritz, et al.
Future Oncology (London, England)|May 15, 2010
Targeting telomerase in hematologic malignancyMichelle F Maritz, Christine E Napier, Victoria W Wen, et al.
Medical Oncology (Northwood, London, England)|January 29, 2026
Two-stage inertial microfluidics enrichment of activated T-cells towards a bead-less chimeric antigen receptor manufacturing protocolMona T Elsemary, Michelle F Maritz, Louise E Smith, et al.
Cytotherapy|May 31, 2024
Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturingMona T Elsemary, Michelle F Maritz, Louise E Smith, et al.
Biological Chemistry|March 23, 2011
Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expressionMichelle F Maritz, Pauline J van der Watt, Nina Holderness, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2022
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisationPouya Dehghankelishadi, Michelle F Maritz, Nicole Dmochowska, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutics|May 25, 2022
Glycogen kinase 3 inhibitor nanoformulation as an alternative strategy to inhibit PD-1 immune checkpointParisa Badiee, Michelle F Maritz, Benjamin Thierry
International Journal of Pharmaceutics|February 17, 2022
High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer modelsPouya Dehghankelishadi, Michelle F Maritz, Parisa Badiee, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Assessment and quantification of telomerase enzyme activityMichelle F Maritz, Laura A Richards, Karen L Mackenzie
ACS Applied Materials & Interfaces|March 31, 2022
Intratumoral Anti-PD-1 Nanoformulation Improves Its BiodistributionParisa Badiee, Michelle F Maritz, Nicole Dmochowska, et al.
Journal of Nanobiotechnology|March 22, 2023
Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effectsPouya Dehghankelishadi, Parisa Badiee, Michelle F Maritz, et al.
Future Oncology (London, England)|May 15, 2010
Targeting telomerase in hematologic malignancyMichelle F Maritz, Christine E Napier, Victoria W Wen, et al.
Medical Oncology (Northwood, London, England)|January 29, 2026
Two-stage inertial microfluidics enrichment of activated T-cells towards a bead-less chimeric antigen receptor manufacturing protocolMona T Elsemary, Michelle F Maritz, Louise E Smith, et al.
Cytotherapy|May 31, 2024
Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturingMona T Elsemary, Michelle F Maritz, Louise E Smith, et al.
Biological Chemistry|March 23, 2011
Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expressionMichelle F Maritz, Pauline J van der Watt, Nina Holderness, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2022
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisationPouya Dehghankelishadi, Michelle F Maritz, Nicole Dmochowska, et al.
Pageof 2